SCHEMBL25677403

SCHEMBL25677403

CC(C)(C)c1cc(C(C)(C)C)c2c(c1)c1ccccc1n2-c1nc(-c2ccccc2)nc(-c2ccccc2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 3/20 0.40
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ TP53 P04637 3/20 0.36
▸ GBA1 P04062 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.31
▸ MAPK1 P28482 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ HSP90AA1 P07900 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ TSHR P16473 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25677406 0.98 ABCG2 (0.40) ABCG2MEN1KMT2ARAB9ATP53
SCHEMBL25677435 0.94 ABCG2 (0.38) ABCG2MEN1KMT2ARAB9ATP53
SCHEMBL25677444 0.93 KDM4E (0.38) ABCG2MEN1KMT2ARAB9ATP53
SCHEMBL25677915 0.92 ABCG2 (0.35) ABCG2MEN1KMT2ARAB9ATP53
SCHEMBL25677429 0.91 ABCG2 (0.35) ABCG2MEN1KMT2ARAB9ATP53
SCHEMBL25677433 0.90 ABCG2 (0.35) ABCG2MEN1KMT2ARAB9ATP53
SCHEMBL25677449 0.90 KIF11 (0.33) L3MBTL1NPSR1MAPK1ALDH1A1MAPT
SCHEMBL25677427 0.89 KDM4E (0.38) ABCG2MEN1KMT2ARAB9ATP53
SCHEMBL25677425 0.89 KIF11 (0.32) L3MBTL1KDM4EATMHSP90AA1LMNA
SCHEMBL25677422 0.89 KIF11 (0.32) L3MBTL1KDM4EATMHSP90AA1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172064-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-01 — — US disclosed
US-20230172064-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172064-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, NQO1, CYP2E1 ABCG2 3616/4885MEN1 212/4885KMT2A 1417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback